Ordination Medizinalrat OA Dr. Peter Poslussny,
Abstract Background Sodium-glucose cotransporter-2 (SGLT2) inhibitors and GLP-1 receptor agonists (GLP-1 RAs) reduce adverse…
Abstract Background Sodium-glucose cotransporter-2 (SGLT2) inhibitors and GLP-1 receptor agonists (GLP-1 RAs) reduce adverse…
In type 2 diabetes with cardiovascular disease, treatment with GLP-1 receptor agonists (GLP-1 RAs) reduced cardiovascular…